Making health happen together
As the largest Canadian-based global health company, a Top 10 player by Gx sales in U.S. and Mexico, and a partner of choice in the Americas for pharmaceutical licensing and product acquisitions, Apotex plays a vital role in supporting the health journeys for millions of people.
Our 2025 Sustainability Report highlights our work as A Force for Health, advancing access to medicines and health products maintaining a focus on quality, and supporting better health outcomes for patients, consumers, and communities through collaboration and partnerships.
Read our 2025 Sustainability Report here
Report highlights include:
Environmental
Our Environmental, Health, and Safety (EHS) management system supports regulatory compliance and enhances efficient management of waste and water resources.
Renewable and low-carbon energy sources accounted for 78% of global electricity consumption, with continued investments in energy efficiency, circularity, LED lighting transitions, and EV fleet deployment.
Advancing our decarbonization journey across our global sites
Social
We work to empower all stakeholders to advance our shared journey of health.
Supporting healthcare system sustainability through access to generic medicines, including in Canada, where Apotex products have contributed to more than $11 billion in estimated savings over the last five years, and more than $50 billion over the last 50 years.
More than $46 million in product donations provided through our 20-year partnership with Health Partners International Canada, supporting access to medicines and health products in nearly 80 countries.
Governance
Our governance structure is designed to ensure accountability for Apotex’s performance and its future impacts.
Updates to the Code of Conduct and enhancements to enterprise risk management processes to support transparency and accountability.
Our giving through the Apotex Global Health Access Fund
Building on Apotex’s legacy of giving, this fund focuses on addressing unequal access to care and low health literacy in communities facing poor social determinants of health, where race, economic status, and other factors create barriers to access. In two years, the fund provided $1.5 million in funding to grant recipients in Canada, the U.S., India, and Mexico.
Global medicine donation program
Apotex works with Health Partners International of Canada (HPIC) to help provide medical and health products to undeserved communities around the world. Through its local and international partnerships, HPIC has helped more than 33 million people across 100 countries to gain access to needed medicines.
Learn more about the Global medicine donation program